Comparative ototoxicity of BB-K8 (amikacin), gentamicin, sisomicin and tobramycin in the guinea pig.
D000161:Acoustic Stimulation; D000583:Amikacin / Q000009:adverse effects*; D000818:Animals; D000900:Anti-Bacterial Agents / Q000009:adverse effects*; D003051:Cochlea / Q000502:physiology; D004594:Electrophysiology; D005839:Gentamicins / Q000009:adverse effects*; D006168:Guinea Pigs; D006311:Hearing Disorders / Q000139:chemically induced*; D007612:Kanamycin / Q000031:analogs & derivatives*; D012018:Reflex / Q000187:drug effects; D012853:Sisomicin / Q000009:adverse effects*; D014031:Tobramycin / Q000009:adverse effects*
D000900:Anti-Bacterial Agents; D005839:Gentamicins; D007612:Kanamycin; D000583:Amikacin; D014031:Tobramycin; D012853:Sisomicin